Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Nuclear Receptor/Transcription Factor-Androgen Receptor (AR)-N-desmethyl Enzalutamide
N-desmethyl Enzalutamide

Chemical Structure : N-desmethyl Enzalutamide

CAS No.: 1242137-16-1

N-desmethyl Enzalutamide (N-desmethyl MDV3100;N-desmethyl MDV 3100;N-desmethyl MDV-3100)

Catalog No.: PC-45933Not For Human Use, Lab Use Only.

Amajor metabolite of Enzalutamide (MDV3100) which is an androgen-receptor (AR) antagonist for treatment of prostate cancer..

Packing Price Stock Quantity
10 mg $120 In stock
50 mg $520 In stock
100 mg $912 In stock

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Amajor metabolite of Enzalutamide (MDV3100) which is an androgen-receptor (AR) antagonist for treatment of prostate cancer.

Physicochemical Properties

M.Wt 450.4094
Formula C20H14F4N4O2S
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO: ≥ 48 mg/mL

Chemical Name/SMILES

Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-

References

1. Tran C, et al. Science. 2009 May 8;324(5928):787-90.

2. Richards J, et al. Cancer Res. 2012 May 1;72(9):2176-82.

3. Gibbons JA, et al. Clin Pharmacokinet. 2015 Oct;54(10):1043-55.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: